UB Paderborn / Katalog / Suche / in CDI

Mobile apps for chemistry in the world of drug discovery

Drug discovery today, 2011-11, Vol.16 (21), p.928-939

2011

Volltextzugriff (PDF)

Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase

Anesthesia and analgesia, 2009, Vol.108 (1), p.316-329

2009

Volltextzugriff (PDF)

The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors

Bioorganic & medicinal chemistry letters, 2016-07, Vol.26 (13), p.3109-3114

2016

Volltextzugriff (PDF)

Potent and Selective α-Ketoheterocycle-Based Inhibitors of the Anandamide and Oleamide Catabolizing Enzyme, Fatty Acid Amide Hydrolase

Journal of medicinal chemistry, 2007-03, Vol.50 (5), p.1058-1068

2007

Volltextzugriff (PDF)

1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase

Bioorganic & medicinal chemistry letters, 2014-03, Vol.24 (5), p.1280-1284

2014

Volltextzugriff (PDF)

New Concerns for Neurocognitive Function during Deep Space Exposures to Chronic, Low Dose-Rate, Neutron Radiation

eNeuro, 2019-07, Vol.6 (4), p.ENEURO.0094-19.2019

2019

Volltextzugriff (PDF)

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

The New England journal of medicine, 2022-01, Vol.386 (4), p.305-315

2022

Volltextzugriff (PDF)

Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

Gastroenterology (New York, N.Y. 1943), 2009-01, Vol.136 (1), p.138-148

2009

Volltextzugriff (PDF)

The Alcohol Intervention Mechanisms Scale (AIMS): Preliminary Reliability and Validity of a Common Factor Observational Rating Measure

Journal of substance abuse treatment, 2016-11, Vol.70, p.28-34

2016

Volltextzugriff (PDF)

A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C

Hepatology (Baltimore, Md.), 2011-08, Vol.54 (2), p.396-405

2011

Volltextzugriff (PDF)

Bladder permeability barrier: recovery from selective injury of surface epithelial cells

American journal of physiology. Renal physiology, 2002-08, Vol.283 (2), p.F242-F253

2002

Volltextzugriff (PDF)

Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C

Hepatology (Baltimore, Md.), 2009-11, Vol.50 (5), p.1360-1369

2009

Volltextzugriff (PDF)

A Functional Polymorphism in the Epidermal Growth Factor Gene Is Associated With Risk for Hepatocellular Carcinoma

Gastroenterology (New York, N.Y. 1943), 2011-07, Vol.141 (1), p.141-149

2011

Volltextzugriff (PDF)

Iron Levels in Hepatocytes and Portal Tract Cells Predict Progression and Outcomes of Patients With Advanced Chronic Hepatitis C

Gastroenterology (New York, N.Y. 1943), 2011-05, Vol.140 (5), p.1490-1500.e3

2011

Volltextzugriff (PDF)

Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C

Hepatology (Baltimore, Md.), 2011-08, Vol.54 (2), p.434-442

2011

Volltextzugriff (PDF)

Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling

Bioorganic & medicinal chemistry, 2008-03, Vol.16 (6), p.2968-2973

2008

Volltextzugriff (PDF)

Excess mortality in patients with advanced chronic hepatitis C treated with long‐term peginterferon

Hepatology (Baltimore, Md.), 2011-04, Vol.53 (4), p.1100-1108

2011

Volltextzugriff (PDF)

Coffee Consumption Is Associated With Response to Peginterferon and Ribavirin Therapy in Patients With Chronic Hepatitis C

Gastroenterology (New York, N.Y. 1943), 2011-06, Vol.140 (7), p.1961-1969

2011

Volltextzugriff (PDF)

Manganese superoxide dismutase gene therapy protects against irradiation-induced cystitis

American journal of physiology. Renal physiology, 2002-12, Vol.283 (6), p.F1304-F1312

2002

Volltextzugriff (PDF)

Lead identification of acetylcholinesterase inhibitors–histamine H 3 receptor antagonists from molecular modeling

Bioorganic & medicinal chemistry, 2008-03, Vol.16 (6), p.2968-2973

2008

Volltextzugriff (PDF)

Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long‐term treatment against cirrhosis (HALT‐C) trial

Hepatology (Baltimore, Md.), 2009-06, Vol.49 (6), p.1828-1837

2009

Volltextzugriff (PDF)

An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C

PloS one, 2011-07, Vol.6 (7), p.e20904

2011

Volltextzugriff (PDF)

Predicting clinical outcomes using baseline and follow‐up laboratory data from the hepatitis C long‐term treatment against cirrhosis trial

Hepatology (Baltimore, Md.), 2011-11, Vol.54 (5), p.1527-1537

2011

Volltextzugriff (PDF)

Novel Benzamide-Based Histamine H3 Receptor Antagonists: The Identification of Two Candidates for Clinical Development

ACS medicinal chemistry letters, 2015-04, Vol.6 (4), p.450-454

2015

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Mobile apps for chemistry in the world of drug discovery

Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase

The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors

Potent and Selective α-Ketoheterocycle-Based Inhibitors of the Anandamide and Oleamide Catabolizing Enzyme, Fatty Acid Amide Hydrolase

1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase

New Concerns for Neurocognitive Function during Deep Space Exposures to Chronic, Low Dose-Rate, Neutron Radiation

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

The Alcohol Intervention Mechanisms Scale (AIMS): Preliminary Reliability and Validity of a Common Factor Observational Rating Measure

A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C

Bladder permeability barrier: recovery from selective injury of surface epithelial cells

Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C

A Functional Polymorphism in the Epidermal Growth Factor Gene Is Associated With Risk for Hepatocellular Carcinoma

Iron Levels in Hepatocytes and Portal Tract Cells Predict Progression and Outcomes of Patients With Advanced Chronic Hepatitis C

Variants in interferon‐alpha pathway genes and response to pegylated interferon‐Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long‐term treatment against cirrhosis trial

Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C

Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling

Excess mortality in patients with advanced chronic hepatitis C treated with long‐term peginterferon

Coffee Consumption Is Associated With Response to Peginterferon and Ribavirin Therapy in Patients With Chronic Hepatitis C

Manganese superoxide dismutase gene therapy protects against irradiation-induced cystitis

Lead identification of acetylcholinesterase inhibitors–histamine H 3 receptor antagonists from molecular modeling

Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long‐term treatment against cirrhosis (HALT‐C) trial

An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C

Predicting clinical outcomes using baseline and follow‐up laboratory data from the hepatitis C long‐term treatment against cirrhosis trial

Novel Benzamide-Based Histamine H3 Receptor Antagonists: The Identification of Two Candidates for Clinical Development

Suchergebnisse filtern